586 related articles for article (PubMed ID: 24365191)
21. Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the "end of the road" for renal denervation?
Epstein M; de Marchena E
J Am Soc Hypertens; 2015 Feb; 9(2):140-9. PubMed ID: 25649995
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous renal denervation and the second generation EnligHTN System.
Chokka RG; Delacroix S; Psaltis PJ; Anavekar NS; Worthley SG
Minerva Cardioangiol; 2014 Feb; 62(1):99-104. PubMed ID: 24500220
[TBL] [Abstract][Full Text] [Related]
23. Renal Sympathetic Denervation: A Viable Option for Treating Resistant Hypertension.
Schlaich MP
Am J Hypertens; 2017 Sep; 30(9):847-856. PubMed ID: 28338871
[TBL] [Abstract][Full Text] [Related]
24. Renal denervation in treatment-resistant hypertension: the need for restraint and more and better evidence.
Persu A; Renkin J; Asayama K; O'Brien E; Staessen JA
Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):739-49. PubMed ID: 23750683
[TBL] [Abstract][Full Text] [Related]
25. Renal denervation: unde venis et quo vadis?
Nähle CP; Düsing R; Schild H
Rofo; 2015 Apr; 187(4):237-47. PubMed ID: 25629384
[TBL] [Abstract][Full Text] [Related]
26. [Renal denervation 2013].
Spinar J; Vítovec J; Spinarová L
Vnitr Lek; 2013 Aug; 59(8):724-9. PubMed ID: 24007231
[TBL] [Abstract][Full Text] [Related]
27. Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system.
Papademetriou V; Tsioufis CP; Sinhal A; Chew DP; Meredith IT; Malaiapan Y; Worthley MI; Worthley SG
Hypertension; 2014 Sep; 64(3):565-72. PubMed ID: 24935940
[TBL] [Abstract][Full Text] [Related]
28. Renal denervation for uncontrolled hypertension: critical review of the evidence.
Chen C; Upadhyay A
Curr Opin Nephrol Hypertens; 2017 Mar; 26(2):114-122. PubMed ID: 27922849
[TBL] [Abstract][Full Text] [Related]
29. Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings.
Esler M
J Am Soc Hypertens; 2014 Aug; 8(8):593-8. PubMed ID: 25151320
[TBL] [Abstract][Full Text] [Related]
30. A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.
Mauri L; Kario K; Basile J; Daemen J; Davies J; Kirtane AJ; Mahfoud F; Schmieder RE; Weber M; Nanto S; Azizi M
Am Heart J; 2018 Jan; 195():115-129. PubMed ID: 29224639
[TBL] [Abstract][Full Text] [Related]
31. Resistant Hypertension and Renal Nerve Denervation.
Denker MG; Cohen DL
Methodist Debakey Cardiovasc J; 2015; 11(4):240-4. PubMed ID: 27057294
[TBL] [Abstract][Full Text] [Related]
32. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension.
Pokushalov E; Romanov A; Corbucci G; Artyomenko S; Baranova V; Turov A; Shirokova N; Karaskov A; Mittal S; Steinberg JS
J Am Coll Cardiol; 2012 Sep; 60(13):1163-70. PubMed ID: 22958958
[TBL] [Abstract][Full Text] [Related]
33. Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension.
Desch S; Okon T; Heinemann D; Kulle K; Röhnert K; Sonnabend M; Petzold M; Müller U; Schuler G; Eitel I; Thiele H; Lurz P
Hypertension; 2015 Jun; 65(6):1202-8. PubMed ID: 25824248
[TBL] [Abstract][Full Text] [Related]
34. Renal denervation in the era of HTN-3. Comprehensive review and glimpse into the future.
Silva JD; Costa M; Gersh BJ; Gonçalves L
J Am Soc Hypertens; 2016 Aug; 10(8):656-70. PubMed ID: 27319336
[TBL] [Abstract][Full Text] [Related]
35. Renal sympathetic denervation using an externally irrigated radiofrequency ablation catheter for treatment of resistant hypertension - Acute safety and short term efficacy.
Yalagudri S; Raju N; Das B; Daware A; Maiya S; Jothiraj K; Ravikishore AG
Indian Heart J; 2015; 67(3):207-13. PubMed ID: 26138176
[TBL] [Abstract][Full Text] [Related]
36. Transradial renal denervation for the treatment of resistant hypertension.
Dong H; Jiang X; Liang T; Zou Y; Guan T; Peng M; Song L; Zhang H; Wu H; Xu B; Yang Y; Gao R
J Invasive Cardiol; 2014 Jul; 26(7):322-7. PubMed ID: 24993989
[TBL] [Abstract][Full Text] [Related]
37. Denervation (ablation) of nerve terminalis in renal arteries: early results of interventional treatment of arterial hypertension in Poland.
Bartuś K; Sadowski J; Kapelak B; Zajdel W; Godlewski J; Bartuś S; Bochenek M; Bartuś M; Żmudka K; Sobotka PA
Kardiol Pol; 2013; 71(2):152-8. PubMed ID: 23575708
[TBL] [Abstract][Full Text] [Related]
38. Renal denervation: current implications and future perspectives.
Xu J; Hering D; Sata Y; Walton A; Krum H; Esler MD; Schlaich MP
Clin Sci (Lond); 2014 Jan; 126(1):41-53. PubMed ID: 24020446
[TBL] [Abstract][Full Text] [Related]
39. Renal sympathetic denervation for the treatment of refractory hypertension.
Leong KT; Walton A; Krum H
Annu Rev Med; 2014; 65():349-65. PubMed ID: 24422574
[TBL] [Abstract][Full Text] [Related]
40. Denervation of nerve terminals in renal arteries: one-year follow-up of interventional treatment of arterial hypertension.
Bartuś K; Sadowski J; Kapelak B; Litwinowicz R; Zajdel W; Godlewski J; Bartuś M; Zmudka K; Chrapusta A; Konstanty-Kalandyk J; Węgrzyn P; Sobotka PA
Kardiol Pol; 2014; 72(5):425-31. PubMed ID: 24408071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
